149 related articles for article (PubMed ID: 12187348)
1. Gigantomastia induced by bucillamine.
Sakai Y; Wakamatsu S; Ono K; Kumagai N
Ann Plast Surg; 2002 Aug; 49(2):193-5. PubMed ID: 12187348
[TBL] [Abstract][Full Text] [Related]
2. Bucillamine-induced gigantomastia with galactorrhea and hyperprolactinaemia.
Mori T; Yokogawa N; Higuchi R; Tsujino M; Shimada K; Sugii S
Mod Rheumatol Case Rep; 2020 Jan; 4(1):122-125. PubMed ID: 33086961
[TBL] [Abstract][Full Text] [Related]
3. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
[TBL] [Abstract][Full Text] [Related]
4. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
Matsushima H; Takayanagi N; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
[TBL] [Abstract][Full Text] [Related]
5. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
[TBL] [Abstract][Full Text] [Related]
6. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
Kim HA; Song YW
Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
[TBL] [Abstract][Full Text] [Related]
7. Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome.
Hase I; Kurasawa K; Takizawa H; Yamaguchi B; Sakuma H; Ishii Y
Intern Med; 2018 Jul; 57(13):1887-1892. PubMed ID: 29434155
[TBL] [Abstract][Full Text] [Related]
8. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
Kishimoto N; Fujii K
Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):321-5. PubMed ID: 12096503
[TBL] [Abstract][Full Text] [Related]
9. Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption.
Izumi A; Katsumi S; Kobayashi N; Niizeki H; Asada H; Miyagawa S
J Dermatol; 2005 May; 32(5):397-401. PubMed ID: 16043905
[TBL] [Abstract][Full Text] [Related]
10. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
[TBL] [Abstract][Full Text] [Related]
11. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
[TBL] [Abstract][Full Text] [Related]
12. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes.
Saito Y; Nei T; Abe S; Usuki J; Azuma A; Nakayama T; Fukuda Y; Kudoh S
Intern Med; 2007; 46(20):1739-43. PubMed ID: 17938531
[TBL] [Abstract][Full Text] [Related]
13. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature.
Isozaki T; Kimura M; Ikegaya N; Arai T; Fujigaki Y; Hishida A; Kaneko E
Clin Investig; 1992 Nov; 70(11):1036-42. PubMed ID: 1472834
[TBL] [Abstract][Full Text] [Related]
14. Yellow nail induced by bucillamine.
Ishizaki C; Sueki H; Kohsokabe S; Nishida H
Int J Dermatol; 1995 Jul; 34(7):493-4. PubMed ID: 7591416
[No Abstract] [Full Text] [Related]
15. Drug eruption due to bucillamine.
Kimura M; Kawada A
Contact Dermatitis; 1998 Aug; 39(2):98-9. PubMed ID: 9746202
[No Abstract] [Full Text] [Related]
16. [A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
Sawa N; Ubara Y; Hara S; Hideyuki K; Tagami T; Yokoyama K; Takemoto F; Yamada A; Mori T; Mikami A; Tachibana S; Nakase K
Ryumachi; 1999 Feb; 39(1):33-8. PubMed ID: 10332215
[TBL] [Abstract][Full Text] [Related]
17. A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritis.
Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T; Fujinami T
Am J Kidney Dis; 1992 Oct; 20(4):411-3. PubMed ID: 1415212
[No Abstract] [Full Text] [Related]
18. Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis.
Yoshida A; Morozumi K; Suganuma T; Sugito K; Ikeda M; Oikawa T; Fujinami T; Takeda A; Koyama K
Am J Nephrol; 1991; 11(4):284-8. PubMed ID: 1799186
[TBL] [Abstract][Full Text] [Related]
19. Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases.
Nakagomi D; Ikeda K; Hirotoshi K; Kobayashi Y; Suto A; Nakajima H
Rheumatol Int; 2013 Mar; 33(3):793-7. PubMed ID: 22090009
[TBL] [Abstract][Full Text] [Related]
20. A case of BOOP developed during bucillamine treatment for rheumatoid.
Lee YH; Kim YR; Ji JD; Shim JJ; Kang KH; Lee JH; Kim HK; Song GG
Korean J Intern Med; 2001 Mar; 16(1):36-9. PubMed ID: 11417303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
